Effect of pH and glucose on cultured human peritoneal mesothelial cells

Scandinavian Journal of Urology and Nephrology

Volumn 33, Issue 4, 1999, Pages 248-256

  Shao, Jin Chang ^a   Yorioka, Noriaki ^a   Nishida, Yoji ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

High glucose; Human peritoneal mesothelial cells; Low pH; Plasminogen activator inhibitor; Thrombin antithrombin III complex; Tissue type plasminogen activator

Indexed keywords

FIBRINOLYTIC FACTOR; GLUCOSE; MANNITOL; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBIN ANTITHROMBIN COMPLEX; THYMIDINE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OSMOLALITY; PERITONEUM; PH; PRIORITY JOURNAL;

ANTITHROMBIN III; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; PEPTIDE HYDROLASES; PERITONEUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032819923     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655999750015862     Document Type: Article

References (38)

1. Jörres A, Gahl GM, Frei U. Peritoneal dialysis fluid biocompatibility: does it really matter? Kidney Int 1994; 46(Suppl 48): S79-86.
2. Dobbie JW, Zaki M, Wilson L. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 1981; 26: 213-23.
3. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204-11.
4. Pollock CA, Ibels LS, Eckstein RP, Graham JC, Caterson RJ, Mahony JF, et al. Peritoneal morphology on maintenance dialysis. Am J Nephrol 1989; 9: 198-204.
5. Gotloib L, Shostack A, Bar-Sella P, Cohen R. Continuous mesothelial injury and regeneration during long term peritoneal dialysis. Perit Dial Bull 1987; 7: 148-55.
6. Topley N, Alobaidi HMM, Davies M, Coles GA, Williams JD, Lloyd D, et al. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404-11.
7. Coles GA, Lewis SL, Williams JD. Host defence and effects of solutions on peritoneal cells. In: Gokal R, Nolph KD, editors. The textbook of peritoneal dialysis. The Netherlands: Kluwer Academic Publishers, 1994: 503-28.
8. Dobbie JW, Lloyd JK, Gall CA. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 1990; 6: 3-12.
9. Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif 1989; 7: 74-85.
10. Gotch FA. Adequacy of peritoneal dialysis. Am J Kidney Dis 1993; 21: 96-8.
11. Quarello F, Bonello F, Boero R, Maffei S, Beltrame G, Belardi P, et al. CAPD in a large population: a 7-year experience. Adv Perit Dial 1989; 5: 56-62.
12. van Bronswijk H, Verbrugh HA, Bos HJ, Heezius ECJM, Oe PL, van der Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9: 197-202.
13. Topley N, Mackenzie R, Petersen MM, Beavis MJ, Williams JD, Thomas N, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574-81.
14. Jorres A, Topley N, Gahl GM. Biocompatibility of peritoneal dialysis fluids. Int J Artif Organs 1992; 15: 79-83.
15. Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41: 1280-5.
16. Holmes CJ. Biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13: 88-94.
17. Witowski J, Breborowicz A, Knapowski J, Oreopoulos D. In vitro culture of human peritoneal mesothelium for investigation of mesothelial dysfunction during peritoneal dialysis. J Physiol Pharmacol 1994; 45: 271-84.
18. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40: 77-9.
19. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39: 343-8.
20. Wieslander A, Lindén T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996; 16(Suppl 1): S114-8.
21. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph KD, editors. The textbook of peritoneal dialysis. The Netherlands: Kluwer Academic Publishers, 1994: 69-113.
22. Di Paolo N. The peritoneal mesothelium: an excretory organ. Perit Dial Int 1989; 9: 151-3.
23. Van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel JH, van Muijen GNP. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-7.
24. Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 1996; 271: R1256-63.
25. Pronk A, de Groot PG, Hoynck van Papendrecht AAGM, Verbrugh HA, Leguit P, van Vroonhoven TJMV, et al. Thrombogenicity and procoagulant activity of human mesothelial cells. Arterioscler Thromb 1992; 12: 1428-36.
26. Baricos WH, Shah SV. Proteolytic enzymes as mediators of glomerular injury. Kidney Int 1991; 40: 161-73.
27. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-70.
28. Gressner AM, Lahme B, Roth S. Attenuation of TGF-β induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Biochem Biophys Res Commun 1997; 231: 457-62.
29. Takenouchi T, Munekata E. Trophic effects of substance P and β-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci 1995; 56: PL479-84.
30. Verger C, Luger A, Moore HL, Nolph KD. Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. Kidney Int 1983; 23: 823-31.
31. Slater ND, Cope GH, Raftery AT. Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. Nephron 1991; 58: 466-71.
32. Gries E, Kopp J, Thomae U, Kuhlmann H. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis. Thromb Haemost 1990; 63: 356-60.
33. Kreisberg JI. Biology of disease: hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Lab Invest 1992; 67: 416-26.
34. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27.
35. Whitaker D, Papadimitriou JM, Walters MNI. The mesothelium: its fibrinolytic properties. J Pathol 1982; 136: 291-9.
36. Myhre-Jensen O, Larsen SB, Astrup T. Fibrinolytic activity in serosal and synovial membranes. Rats, guinea pigs, and rabbits. Arch Pathol 1969; 88: 623-30.
37. Porter JM, McGregor Jr FH, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80-2.
38. Topley N, Kaur D, Petersen MM, Jörres A, Passlick-Deetjen J, Coles GA, et al. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function. Kidney Int 1996; 49: 1447-56.